Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (5506)	4/21/2008 12:31:31 PM
From: John Koligman	Read Replies (1) \| Respond to of 42652

I'll grant you that many of these do address a very small user base, it's just that this particular case seemed a bit different. I'm a bit cynical, but if drugs like Avastin really should be priced at 100k a year (I think it has a larger user base potentially - for cancer), then we probably need some type of subsidy to spread the cost around and prevent the people using them from going bankrupt. The alternative is rationing, either by price or policy. I'm somewhat fearful of the future as more and more of these will be coming, couple that with machines like the new 100 million dollar particle accelerator that can be used for cancer, along with the baby boomer deluge, and we have a serious situation in the near future. Regards, John PS - The Frontline program didn't address it as I recall, but I wonder how much these drugs are in the various plans that were covered around the world. Since Japan clamps down on hospital costs, do they also on drugs???